|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.31 USD | +3.47% |
|
+7.79% | -3.49% |
| 07-31 | PTC Therapeutics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | PTC Q2 Swings to Profit, Revenue Rises; Ups Guidance | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 78.01 | 89.55 | 85.99 |
| Spread/Res. | -6.02% | -18.14% | -14.75% |
| Spread/Supp. | +7.79% | +16.70% | +48.61% |
| Support | 68.01 | 62.82 | 49.33 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PTCT Stock
- Charts PTC Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
